RE:RE:RE:The end quickly approacheth So then big pharma would neet to cut research and development? Pharma needs big profits to keep up with developing better and safer drugs. With less regulation and tax cuts big pharma will make great profit while cutting drug prices further. Don't forget Valeant has adjusted all its pricing and is only increasing prices based on average and in single digits. Valeant has adapted to the trump model. Keep also in mind B&L is outside of the pharma space.I'm not invested in Valeant. I am invested in B&L and Salix and Derma. I know a few people that are actually excited about Broadalumab since the other stuff they are taking works only partially but in the winter months it gets worse even on the meds. I'm not selling my shares because the whole sector is getting manipulated. Eventually Valeant will get bought out for 10-15 billion plus absorb the remainder of the debt. Their debt in the hands of a more stable company is very attractive to debt holders. The way Valeant trades we could hit 40 bucks CDN in a flash. GL!